VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IMCC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IMCCIM Cannabis Corp.
$0.14$438442
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

IMCC logoIM Cannabis Corp.(IMCC)Earnings, Financials & Key Ratios

IMCC•NASDAQ
$0.14
Price updated Jun 27, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryCannabis and cannabinoid product companies
AboutIM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.Show more
  • Revenue$55M+1.3%
  • EBITDA-$10M-19.6%
  • Net Income-$11M-6.9%
  • EPS (Diluted)-2.67+40.8%
  • Gross Margin17.7%+13.1%
  • EBITDA Margin-17.6%-18.1%
  • Operating Margin-21.17%-11.8%
  • Net Margin-20.68%-5.6%

IMCC Price & Volume

IM Cannabis Corp. (IMCC) stock price & volume — 10-year historical chart

Loading chart...

Persistent Revenue Contraction and Eroding Equity Base

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Liquidity and Solvency Risk

Key Thesis Takeaways

  • IM Cannabis Corp.
  • faces a challenging fundamental outlook characterized by a 49.4% year-over-year revenue contraction in 2026Q1 and a precarious liquidity position evidenced by a current ratio of 0.55.
  • The company's strategic pivot to Israeli and German markets has yet to yield operating leverage, as evidenced by a -19.3% operating margin and a negative equity base of -$5.0 million.
  • Investors should remain cautious regarding the firm's ability to sustain operations without further dilutive financing, given the persistent net losses and the exhaustion of its liquidity buffer.

Verdict Logic

the company's inability to maintain a current ratio above 1.0, which sits at 0.55 as of 2026Q1, suggests a high risk of insolvency and continued shareholder dilution.

IMCC Growth Metrics

IM Cannabis Corp. (IMCC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years28.06%
3 Years0.24%
TTM-18.99%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-136.72%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-18.02%

Return on Capital

10 Years-208.69%
5 Years-272.04%
3 Years-439.86%
Last Year-1158.7%

IMCC Recent Earnings

IM Cannabis Corp. (IMCC) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 6/12 qtrs (55%)●Beat Revenue 1/12 qtrs (9%)
Q2 2026Latest
May 13, 2026
Metric
Actual
Est
EPS
$0.28
—
Rev
—
—
Q2 2026
Mar 30, 2026
Metric
Actual
Est
EPS
$0.86-1100.5%
$0.09
Rev
$8M-47.7%
$16M
Q4 2025
Nov 13, 2025
Metric
Actual
Est
EPS
$0.54-2234.6%
$0.02
Rev
$10M-30.4%
$14M
Q3 2025
Aug 12, 2025
Metric
Actual
Est
EPS
$0.07+48.8%
$0.14
Rev
$9M-27.6%
$13M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 13, 2026
$0.28
—
Q2 2026Mar 30, 2026
$0.86vs $0.09-1100.5%
$8Mvs $16M-47.7%
Q4 2025Nov 13, 2025
$0.54vs $0.02-2234.6%
$10Mvs $14M-30.4%
Q3 2025Aug 12, 2025
$0.07vs $0.14+48.8%
$9Mvs $13M-27.6%
Based on last 12 quarters of dataView full earnings history →

Latest IMCC News

Recent stock market news and headlines for IM Cannabis Corp. (IMCC)

PRNewsWire·Jun 18, 2026
IM Cannabis Corp. Enters into Letter of Intent to Sell its European Activities, Expects to Significantly Reduce Debt by CAD$10.5 million

Transaction Expected to Streamline Operations, Retain Israeli Business, Improve Working Capital through debt reduction and Cash Flow While Enabling the Pursuit of New Investment Opportunities as Previously Announced TORONTO and GLIL YAM, Israel, June 18, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC), a medical cannabis company with operations in Israel and Germany, is pleased to announce that it has entered into a non-binding letter of intent (the "Letter of Intent") with Slil.com Holding Ltd., a privately-held Israeli entity beneficially owned and controlled by Oren Shuster, the Company's Chief Executive Officer, a director and debtholder of IMC ("Slil"), pursuant to which the Company has agreed to sell to Slil its European-focused assets (the "Transaction").

Peers Comparison

Key metrics vs top competitors for IM Cannabis Corp. (IMCC)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
IMCC logoIMCCIM Cannabis Corp.Current
$0.14$438.44K-0.081.3%-20.68%——
TLRY logoTLRYTilray Brands, Inc.
$4.64$540.66M-0.144.84%-252.55%-136.55%—
CGC logoCGCCanopy Growth Corporation
$0.95$364.16M-1.525.8%-91.63%-38.64%—
ACB logoACBAurora Cannabis Inc.
$2.83$175.3M-1.87-6.37%-24.14%-13.4%—
CRON logoCRONCronos Group Inc.
$2.81$1.05B-114.6964.4%-0.98%-0.18%—
OGI logoOGIOrganigram Global Inc.
$1.03$145M-10.4416.42%-9.7%-6.76%—

Compare IMCC vs Peers

IM Cannabis Corp. (IMCC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs TLRY

Most directly comparable listed peer for IMCC.

Scale Benchmark

vs IIPR

Larger-name benchmark to compare IMCC against a more recognizable public peer.

Peer Set

Compare Top 5

vs TLRY, CGC, ACB, CRON

Get notified when IMCC posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

IMCC Frequently Asked Questions

IM Cannabis Corp. (IMCC) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is IM Cannabis Corp.'s revenue?

IM Cannabis Corp. (IMCC) reported $44.1M in revenue for fiscal year 2025.

How fast is IM Cannabis Corp. growing?

IM Cannabis Corp. (IMCC) grew revenue by 1.3% over the past year. Growth has been modest.

Is IMCC profitable?

IM Cannabis Corp. (IMCC) reported a net loss of $11.1M for fiscal year 2025.

Dividend & Returns
What is IM Cannabis Corp.'s free cash flow?

IM Cannabis Corp. (IMCC) had negative free cash flow of $1.7M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in IMCC back in 2003?

Total return calculator · dividends reinvested · 23+ years of data

See returns →